Items 41 to 60 of 149 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
    Cat. No. Name CAS No. Description
    KI3290 CO-1686 1374640-70-6 CO-1686 is a potent and mutant-selective EGFR inhibitor....
    KI3460 CP-724714 537705-08-1 CP-724,714 is a selective inhibitor of epidermal growth factor 2(erbB/2) tyrosine kinase....
    KI4279 CP673451 343787-29-1 ....
    KI0343 Crizotinib(PF-02341066) 877399-52-5 Crizotinib is a potent and selective dual inhibitor of mesenchymal??pithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)....
    KI1220 CUDC-101 1012054-59-9 CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively....
    KI0095 CYT387 1056634-68-4 CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 and 18 nM, respectively....
    KI0352 Dasatinib 302962-49-8 Dasatinib is a potent dual Src/Abl inhibitor....
    KI0437 Dovitinib Dilactic acid (TKI258 Dilactic acid) 852433-84-2 Dovitinib is a highly potent inhibitor of vascular endothelial growth factor receptor (VEGFR) 1, VEGFR2, VEGFR3, platelet-derived growth factor receptor (PDGFR) β, and fibroblast growth factor growth (FGFR)1, FGFR2, and FGFR3 (fibroblast growth factor receptors 1, 2, and 3)....
    KI1057 E-3810 117976-90-6 E-3810 is a novel dual inhibitor of the VEGF and FGF receptors....
    KI2658 E-7050 928037-13-2 E-7050 is novel small molecule inhibitor of the c-Met and VEGFR-2 tyrosine kinases....
    KI3395 E7080 (Lenvatinib) 417716-92-8 E7080 is an orally active inhibitor of multiple receptor tyrosine kinases, mostly for VEGFR2 (KDR)/VEGFR3 (Flt-4)....
    KI2807 EMD-1214063 1100598-32-0 EMD-1214063 is a potent and selective inhibitor of c-Met....
    KI3882 EPZ004777 1338466-77-5 ....
    KI0303 Erlotinib Hydrochloride 183319-69-9 Erlotinib is a selective, orally available small-molecule inhibitor of the HER1/EGFR tyrosine kinase domain, used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer....
    KI4041 Fasudil hydrochloride 105628-07-7 ....
    KI2647 FLLL32 1226895-15-3 FLLL32 is a novel and small molecule inhibitor of the STAT3 pathway....
    KI6095 FLT3-IN-1 1370256-78-2 ....
    KI0309 Gefitinib 184475-35-2 Gefitinib, a synthetic anilinoquinazoline, directly and specificly inhibits tyrosine kinase (TK) phosphorylation on the epidermal growth factor receptor (EGFR) by competing for the ATP-binding site, which leads to suppression of the EGFR pathway (HER-kinase axis)....
    KI3963 GSK1349572 1051375-16-6 ....
    KI0552 GSK1838705A 1116235-97-2 GSK1838705A is a small-molecule IGF-IR and the insulin receptor inhibitor....

Items 41 to 60 of 149 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction